HCVAX
Price
$12.39
Change
-$0.06 (-0.48%)
Updated
Sep 11 closing price
Net Assets
137.89M
ONCFX
Price
$13.26
Change
+$0.03 (+0.23%)
Updated
Sep 11 closing price
Net Assets
4.41B
Interact to see
Advertisement

HCVAX vs ONCFX

HCVAX vs ONCFX Comparison Chart in %
View a ticker or compare two or three
VS
HCVAX vs. ONCFX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCVAX is a Hold and ONCFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ONCFX has more cash in the bank: 4.41B vs. HCVAX (138M). ONCFX pays higher dividends than HCVAX: ONCFX (3.53) vs HCVAX (3.05). HCVAX was incepted earlier than ONCFX: HCVAX (22 years) vs ONCFX (30 years). HCVAX (1.01) is less costly to investors than ONCFX (0.67). HCVAX is a more actively managed with annual turnover of: 27.00 vs. ONCFX (11.00). HCVAX has a lower initial minimum investment than ONCFX: HCVAX (2000) vs ONCFX (1000000). ONCFX IRA initial investment is lower compared to HCVAX: ONCFX (1000000) vs HCVAX (2000). HCVAX annual gain was more profitable for investors over the last year : 5.05 vs. ONCFX (2.95). HCVAX return over 5 years is better than : 14.42 vs. ONCFX (9.43).
HCVAXONCFXHCVAX / ONCFX
Total Expense Ratio1.010.67151%
Annual Report Gross Expense Ratio1.010.67151%
Fund Existence22 years30 years-
Gain YTD3.6882.652139%
Front Load6%N/A-
Min. Initial Investment200010000000%
Min. Initial Investment IRA200010000000%
Net Assets138M4.41B3%
Annual Yield % from dividends3.053.5386%
Returns for 1 year5.052.95171%
Returns for 3 years31.3324.52128%
Returns for 5 years14.429.43153%
Returns for 10 years57.3037.20154%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PBEAX27.62N/A
N/A
PGIM Jennison Value A
OTCFX63.08N/A
N/A
T. Rowe Price Small-Cap Stock
OGIYX57.11N/A
N/A
Invesco Global Opportunities Y
MSPRX22.93N/A
N/A
Morgan Stanley Inst Advantage C
RIERX13.49N/A
N/A
RBC International Equity R6